Patent Expiry
ESPR: NEXLETOL: recorded patent 11926584 expiry
June 19, 2040 · BEMPEDOIC ACID. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 19, 2040
- Company
- Esperion Therapeutics, Inc. (ESPR)
- Drug
- BEMPEDOIC ACID
BioSniper AIPage context preserved
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
NEXLETOL: recorded patent 11926584 expiry
Orange Book application NDA211616, product 001, listed patent 11926584 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- BEMPEDOIC ACID